SARS and MERS: recent insights into emerging coronaviruses

de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology
DOI 10.1038/nrmicro.2016.81

Cited by (1,002)

Items 201–300 of 1,002

  1. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
    Christopher John Neufeldt, Berati Cerikan, Mirko Cortese, Jamie Frankish, Ji‐Young Lee, Agnieszka Płóciennikowska, Florian Heigwer, Vibhu Ranjan Prasad, Sebastian Joecks, Sandy S. Burkart et al. · 2022 · Communications Biology
  2. Sanitizing agents for virus inactivation and disinfection
    Lin, Qianyu, Lim, Jason Y. C., Xue, Kun, Yew, Pek Yin Michelle, Owh, Cally, Chee, Pei Lin, Loh, Xian Jun · 2020 · VIEW
  3. Diabetes and COVID-19: A systematic review on the current evidences
    Alireza Abdi, Milad Jalilian, Pegah Ahmadi Sarbarzeh, Željko Vlaisavljević · 2020 · Diabetes Research and Clinical Practice
  4. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies
    Elahe Seyed Hosseini, Narjes Riahi Kashani, Hossein Nikzad, Javid Azadbakht, Hassan Hassani Bafrani, Hamed Haddad Kashani · 2020 · Virology
  5. The novel zoonotic COVID-19 pandemic: An expected global health concern
    Carlo Contini, Mariachiara Di Nuzzo, Nicole Barp, Aurora Bonazza, Roberto DE GIORGIO, Mauro G. Tognon, Salvatore Rubino · 2020 · The Journal of Infection in Developing Countries
  6. A Trial of Lopinavir–Ritonavir in Covid-19
    Piero D. Dalerba, Bruce Levin, John L Thompson · 2020 · New England Journal of Medicine
  7. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication
    Oudshoorn, Diede, Rijs, Kevin, Limpens, Ronald W. A. L., Groen, Kevin, Koster, Abraham J., Snijder, Eric J., Kikkert, Marjolein, Bárcena, Montserrat · 2017 · mBio
  8. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
    Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz · 2020 · Frontiers in Immunology
  9. COVID-19 and social distancing
    Meirui Qian, Jian‐Li Jiang · 2020 · Journal of Public Health
  10. SARS-CoV-2 infection, disease and transmission in domestic cats
    Natasha N. Gaudreault, Jessie D. Trujillo, Mariano Carossino, David A. Meekins, Igor Morozov, Daniel W. Madden, Sabarish V. Indran, Dashzeveg Bold, Velmurugan Balaraman, Taeyong Kwon et al. · 2020 · Emerging Microbes & Infections
  11. Coronavirus genomic RNA packaging
    Paul S. Masters · 2019 · Virology
  12. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
    Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, Benjamin Jung, Shannon Steele, Khosrow Adeli · 2020 · Physiology
  13. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins
    Hongzhu Cui, Ziyang Gao, Ming Liu, Ming Liu, Sun Mo, Winnie Mkandawire, Oleksandr Narykov, Mo Sun, Dmitry Korkin · 2020 · Viruses
  14. Coronaviruses: a paradigm of new emerging zoonotic diseases
    Cristiano Salata, Arianna Calistri, Cristina Parolin, Giorgio Palù · 2019 · Pathogens and Disease
  15. Antiviral drug discovery: preparing for the next pandemic
    Catherine S. Adamson, Kelly Chibale, Rebecca J. M. Goss, Marcel Jaspars, David J. Newman, Rosemary Ann Dorrington · 2021 · Chemical Society Reviews
  16. Zoonotic spillover: Understanding basic aspects for better prevention
    Joel Henrique Ellwanger, José Artur Bogo Chies · 2021 · Genetics and Molecular Biology
  17. Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?
    Sangiliyandi Gurunathan, Muhammad Qasim, Youngsok Choi, Jeong Tae, Chankyu Park, Kwonho Hong, Jin‐Hoi Kim, Hyuk Song · 2020 · Nanomaterials
  18. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
    Oreste Gallo, Luca Giovanni Locatello, Alessio Mazzoni, Luca Novelli, Francesco Annunziato · 2020 · Mucosal Immunology
  19. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
    Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel Martin Altmann, Rosemary Jane Boyton · 2021 · npj Vaccines
  20. What to do next to control the 2019-nCoV epidemic?
    Fu‐Sheng Wang, Chao Zhang · 2020 · The Lancet
  21. Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors
    Seri Jo, Hyojin Kim, Suwon Kim, Dong Hae Shin, Mi Sun Kim · 2019 · Chemical Biology & Drug Design
  22. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
    Maria Chiara Sportelli, Margherita Izzi, Ekaterina A. Kukushkina, Syed Imdadul Hossain, Rosaria Anna Picca, Nicoletta Ditaranto, Nicola Cioffi · 2020 · Nanomaterials
  23. COVID-19, a worldwide public health emergency
    Mariali Palacios-Cruz, Edgar Santos, M.A. Velázquez Cervantes, M. León Juárez · 2020 · Revista Clínica Española (English Edition)
  24. Point-of-care testing detection methods for COVID-19
    Qi Song, Xindi Sun, Ziyi Dai, Yibo Gao, Xiuqing Gong, Bingpu Zhou, Jinbo Wu, Weijia Wen · 2021 · Lab on a Chip
  25. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
    E. Susan Amirian, Julie K. Levy · 2020 · One Health
  26. SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases
    Mujahed I. Mustafa, Abdelrafie Mohamed Makhawi · 2020 · Journal of Clinical Microbiology · Retracted
  27. SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death
    Yuan Yue, Neel R. Nabar, Chong-Shan Shi, Olena Kamenyeva, Xun Xiao, Il‐Young Hwang, Min Wang, John H. Kehrl · 2018 · Cell Death and Disease
  28. Challenges and recent progress in drug discovery for tropical diseases
    Manu De Rycker, Beatriz Baragaña, Suzanne Duce, Ian Hugh Gilbert · 2018 · Nature
  29. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
    Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, Lauren Castellana, Kasirajan Ayyanathan, Fabian L. Cardenas‐Diaz, Edward E. Morrisey et al. · 2021 · Cell Reports
  30. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
    Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi, Rita Casetti, Eleonora Tartaglia, Eleonora Lalle, Alessandra D’Abramo et al. · 2020 · Cell Death and Differentiation
  31. Nosocomial Transmission of Coronavirus Disease 2019: A Retrospective Study of 66 Hospital-acquired Cases in a London Teaching Hospital
    Hannah M. Rickman, Tommy Rampling, Karen Shaw, Gema Martinez-Garcia, Leila Hail, Pietro G. Coen, Maryam Shahmanesh, Gee Yen Shin, Eleni Nastouli, Catherine F. Houlihan · 2020 · Clinical Infectious Diseases
  32. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
    Yin-Feng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiang-Ping Li, Pingping Zhou, Xin-Chun Chen, Zhe Liu, Xiao Zhang et al. · 2021 · ACS Nano
  33. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
    Robyn Ralph, Jocelyne M. Lew, Tiansheng Zeng, Magen Ellen Francis, Bei Xue, Melissa Roux, Ali Toloue Ostadgavahi, Salvatore Rubino, Nicholas J. Dawe, Mohammed N. Al‐Ahdal et al. · 2020 · The Journal of Infection in Developing Countries
  34. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India
    Nitesh Gupta, Sumita Pravesh Agrawal, Pranav Ish, Suruchi Mishra, Rajni Gaind, Usha Ganapathy, Balvinder Singh, Manas Kamal Sen · 2020 · Monaldi Archives for Chest Disease
  35. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
    Nikolaus Osterrieder, Luca D. Bertzbach, Kristina Dietert, Azza Abdelgawad, Daria Vladimirova, Dušan Kunec, Donata Hoffmann, Martin Beer, Achim Dieter Gruber, Jakob Trimpert · 2020 · Viruses
  36. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
    Taisho Yamada, Seiichi Sato, Yuki Sotoyama, Yasuko Orba, Hirofumi Sawa, Hajime Yamauchi, Michihito Sasaki, Akinori Takaoka · 2021 · Nature Immunology
  37. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study
    Chen Shi, Cong Wang, Hanxiang Wang, Chao Yang, Fei Cai, Fang Zeng, Fang Cheng, Yihui Liu, Taotao Zhou, Bin Deng et al. · 2020 · Clinical and Translational Science
  38. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
    Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomáš Cihlář et al. · 2020 · Nature Communications
  39. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
    Shuofeng Yuan, Xin Yin, Xiangzhi Meng, Jasper Fuk‐Woo Chan, Zi‐Wei Ye, Laura Riva, Lars Pache, Chris Chun-Yiu Chan, Pok-Man Lai, Chris Chung‐Sing Chan et al. · 2021 · Nature
  40. Immune responses and pathogenesis of SARS‐CoV ‐2 during an outbreak in Iran: Comparison with SARS and MERS
    Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli · 2020 · Reviews in Medical Virology
  41. Natural history of COVID-19 and current knowledge on treatment therapeutic options
    Wagner Gouvêa dos Santos · 2020 · Biomedicine & Pharmacotherapy
  42. Psychiatric face of COVID-19
    Luca Steardo, Luca Steardo, Alexei Verkhratsky · 2020 · Translational Psychiatry
  43. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century
    Vivaldo Gomes da Costa, Marcos Lázaro Moreli, Marielena Vogel Saivish · 2020 · Archives of Virology
  44. An overview on the seven pathogenic human coronaviruses
    Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, Milad Zandi · 2021 · Reviews in Medical Virology
  45. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2
    Tove Hoffman, Karolina Nissen, Janina Krambrich, Bengt J. Rönnberg, Dario Akaberi, Mouna Esmaeilzadeh, Erik Salaneck, Johanna Frida Lindahl, Åke Lundkvist · 2020 · Infection Ecology & Epidemiology
  46. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
    T.T. Favas, Priya Dev, Rameshwar Nath Chaurasia, Kamalesh Chakravarty, Rahul Mishra, Deepika Joshi, Vijaya Nath Mishra, Anand Kumar, Varun Kumar Singh, Manoj Pandey et al. · 2020 · Neurological Sciences
  47. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients
    Jing Yuan, Rougrong Zou, Lijiao Zeng, Shanglong Kou, Jianfeng Lan, Xiaohe Li, Yanhua Liang, Xiaoyan Ding, Guoyu Tan, Shenghong Tang et al. · 2020 · Inflammation Research
  48. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
    Matteo Chiara, Anna Maria D’Erchia, Carmela Gissi, Caterina Manzari, Antonio Parisi, Nicoletta Resta, Federico Zambelli, Ernesto Picardi, Giulio Pavesi, David Stephen Horner et al. · 2020 · Briefings in Bioinformatics
  49. The Immune Response and Immunopathology of COVID-19
    Esmaeil Mortaz, Payam Tabarsi, Mohammad Varahram, Gert Folkerts, Ian Michael Adcock · 2020 · Frontiers in Immunology
  50. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
    SangJoon Lee, Rudragouda Channappanavar, Thirumala‐Devi Kanneganti · 2020 · Trends in Immunology
  51. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
    Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, Christophe C. Pannecouque, Erik De Clercq, Luis Menéndez‐Arias, Xinyong Liu, Peng Zhan · 2021 · Chemical Society Reviews
  52. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
    Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Kumar Tyagi, Arvind Bhushan, Madhu Rathore · 2020 · Journal of Biomolecular Structure and Dynamics
  53. An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
    Yasin Orooji, Hessamaddin Sohrabi, Nima Hemmat, Fatemeh Oroojalian, Behzad Baradaran, Ahad Mokhtarzadeh, Mohamad Mohaghegh, Hassan Karimi‐Maleh · 2020 · Nano-Micro Letters
  54. The architecture of the SARS-CoV-2 RNA genome inside virion
    Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Yu Rao, Juan Chen, Naijing Hu, Minnan Yang, Xiaorui Xing, Yongle Wang, Manman Li et al. · 2021 · Nature Communications
  55. Persistence of Pathogens on Inanimate Surfaces: A Narrative Review
    Jan-Erik Wißmann, Lisa Kirchhoff, Yannick Brüggemann, Daniel Tödt, Joerg Steinmann, Eike Steinmann · 2021 · Microorganisms
  56. COVID-19 Infection
    John R. Greenland, Marilyn Diane Michelow, Linlin Wang, Martin J. London · 2020 · Anesthesiology
  57. Prevalence and associated factors of depression and anxiety among nurses during the outbreak of COVID-19 in China: A cross-sectional study
    Rujun Zheng, Yuhong Zhou, Yan Fu, Qiufen Xiang, Fang Cheng, Huaying Chen, Huiqiong Xu, Lan Fu, Xiaoling Wu, Mei Feng et al. · 2020 · International Journal of Nursing Studies
  58. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
    Colin D. Funk, Craig A. Laferrière, Ali Ardakani · 2020 · Frontiers in Pharmacology
  59. Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art
    Nastaran Taleghani, Fariborz Taghipour · 2020 · Biosensors and Bioelectronics
  60. Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
    Haixia Su, Sheng Yao, Wenfeng Zhao, Yumin Zhang, Jia Liu, Qiang Shao, Qingxing Wang, Minjun Li, Hang Xie, Weijuan Shang et al. · 2021 · Nature Communications
  61. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
    Zezhong Liu, Wei Xu, Shuai Xia, Chenjian Gu, Xinling Wang, Qian Wang, Jie Zhou, Yanling Wu, Xia Cai, Di Qu et al. · 2020 · Signal Transduction and Targeted Therapy
  62. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
    Bingqing Xia, Xu-Rui Shen, Yang He, Xiaoyan Pan, Feng‐Liang Liu, Yi Wang, Feipu Yang, Sui Fang, Yan Ling Wu, Zilei Duan et al. · 2021 · Cell Research
  63. One year update on the COVID-19 pandemic: Where are we now?
    Sanjay Kumar Mishra, Timir Tripathi · 2020 · Acta Tropica
  64. Climate change, environment pollution, COVID-19 pandemic and mental health
    Donatella Marazziti, Paolo Cianconi, Federico Mucci, Lara Foresi Crowther, Ilaria Chiarantini, Alessandra Della Vecchia · 2021 · The Science of The Total Environment
  65. Clinical manifestation and disease progression in COVID-19 infection
    Ping‐Hsing Tsai, Wei-Yi Lai, Yi-Ying Lin, Yung‐Hung Luo, Yi-Tsung Lin, Hsiao-Kang Chen, Yuh-Min Chen, Yi-Chun Lai, Li-Chiao Kuo, Shew-Dan Chen et al. · 2020 · Journal of the Chinese Medical Association
  66. Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome
    Zhang, Kaiming, Zheludev, Ivan N., Hagey, Rachel J., Haslecker, Raphael, Hou, Yixuan J., Kretsch, Rachael, Pintilie, Grigore D., Rangan, Ramya, Kladwang, Wipapat, Li, Shanshan et al. · 2021 · Nature Structural & Molecular Biology
  67. Porcine Deltacoronavirus Infection and Transmission in Poultry, United States1
    Patricia A. Boley, Moyasar A. Alhamo, Geoffrey Lossie, Kush Kumar Yadav, Marcia Vasquez-Lee, Linda J. Saif, Scott P. Kenney · 2020 · Emerging infectious diseases
  68. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis
    on behalf of COVID-19 evidence and recommendations working group, Shu Yang, Peihua Cao, Peipei Du, Ziting Wu, Zian Zhuang, Lin Yang, Xuan Yu, Qi Xin Zhou, Xixi Feng et al. · 2020 · Annals of Translational Medicine
  69. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
    Wei Jian Zhu, Catherine Z. Chen, Kirill Gorshkov, Miao Xu, Donald C. Lo, Wei Zheng · 2020 · SLAS DISCOVERY
  70. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
    Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato · 2020 · Frontiers in Immunology
  71. CRISPR-Cas systems for diagnosing infectious diseases
    Anastasiya Kostyusheva, Sergey Brezgin, Yu.Yu. Babin, Irina Vasilyeva, Dieter Glebe, Dmitry S. Kostyushev, Vladimir Chulanov · 2021 · Methods
  72. Mesoporous silica nanoparticles for pulmonary drug delivery
    Alba García‐Fernández, Félix Sancenón, Ramón Martínez‐Máñez · 2021 · Advanced Drug Delivery Reviews
  73. COVID-19: Knowns, Unknowns, and Questions
    Stuart M. Weston, Matthew B. Frieman · 2020 · mSphere
  74. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract
    Michail Galanopoulos, Filippos Gkeros, Aris Doukatas, Grigorios Karianakis, Christos Pontas, Nikolaos Tsoukalas, Nikos Viazis, Christos N. Liatsos, Gerassimos J. Mantzaris · 2020 · World Journal of Gastroenterology
  75. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
    Dario Akaberi, Janina Krambrich, Jiaxin Ling, Luni Chen, Göran Hedenstierna, Josef D. Järhult, Johan Lennerstrand, Åke Lundkvist · 2020 · Redox Biology
  76. Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
    Muhammad Tahir ul Qamar, Saman Saleem, Usman Ali Ashfaq, Amna Bari, Farooq Anwar, Safar M. Alqahtani · 2019 · Journal of Translational Medicine
  77. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
    Melissa L. Boby, Daren Fearon, Matteo Ferla, Mihajlo Filep, L. Koekemoer, Matthew C. Robinson, John D. Chodera, Alpha A. Lee, Nir London, Annette von Delft et al. · 2023 · Science
  78. Azithromycin in viral infections
    Madeleine Oliver, Timothy Hinks · 2020 · Reviews in Medical Virology
  79. In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach
    Papia Chowdhury · 2020 · Journal of Biomolecular Structure and Dynamics
  80. Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
    Patrícia R. M. Rocco, Pedro Leme Silva, Fernanda Ferreira Cruz, Marco Antonio C. Melo-Junior, Paulo Fernando Guimarães Morando Marzocchi Tierno, Marcos A. Moura, Luís Frederico G. De Oliveira, Cristiano C. Lima, Ezequiel Aparecido dos Santos, Walter F. Junior et al. · 2020 · European Respiratory Journal
  81. In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2
    DSNBK Prasanth, Manikanta Murahari, Vivek Chandramohan, Siva Prasad Panda, A. Lakshmana Rao, Chakravarthi Guntupalli · 2020 · Journal of Biomolecular Structure and Dynamics
  82. Modeling the viral dynamics of SARS-CoV-2 infection
    Sunpeng Wang, Yang Pan, Quanyi Wang, Hongyu Miao, Ashley N. Brown, Libin Rong · 2020 · Mathematical Biosciences
  83. A Liquid Metal Mediated Metallic Coating for Antimicrobial and Antiviral Fabrics
    Ki Yoon Kwon, Samuel Cheeseman, Alba Frias‐De‐Diego, Haeleen Hong, Jiayi Yang, Woojin Jung, Hong Feng Yin, Billy James Murdoch, Frank Scholle, Nathan Crook et al. · 2021 · Advanced Materials
  84. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
    Maria Trovato, Rossella Sartorius, Luciana D’Apice, Roberta Manco, Piergiuseppe De Berardinis · 2020 · Frontiers in Immunology
  85. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia
    Abolfazl Torabi, Esmaeil Mohammadbagheri, Nader Akbari Dilmaghani, Amir‐Hossein Bayat, Mobina Fathi, Kimia Ghazi Vakili, Rafieh Alizadeh, Omidvar Rezaeimirghaed, Mohammadreza Hajiesmaeili, Mahtab Ramezani et al. · 2020 · ACS Chemical Neuroscience
  86. CORONAVIRUS COVID-19 DISEASE, MENTAL HEALTH AND PSYCHOSOCIAL SUPPORT
    Gordana Stankovska, Imran Memedi, Dimitar Dimitrovski · 2020 · Society Register
  87. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
    Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy, Dong‐Qing Wei · 2020 · Journal of Biomolecular Structure and Dynamics
  88. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
    Francesco Domenico Moccia, Andrea Gerbino, Vincenzo Lionetti, Michele Miragoli, Luca Munaron, Pasquale Pagliaro, Teresa Pasqua, Claudia Renata Rezende Penna, Carmine Rocca, Michele Samaja et al. · 2020 · GeroScience
  89. Innate and adaptive immune responses against coronavirus
    Arezoo Hosseini, Vida Hashemi, Navid Shomali, Faezeh Asghari, Tohid Gharibi, Morteza Akbari, Saber Gholizadeh, Abbas Jafari · 2020 · Biomedicine & Pharmacotherapy
  90. Air−Liquid Interface Cultures of the Healthy and Diseased Human Respiratory Tract: Promises, Challenges, and Future Directions
    Domizia Baldassi, Bettina Gabold, Olivia M. Merkel · 2021 · Advanced NanoBiomed Research
  91. Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
    Chuan‐bin Sun, Yue-ye Wang, Geng-hao Liu, Zhe Liu · 2020 · Frontiers in Public Health
  92. Parental Engagement in Children's Online Learning During COVID-19 Pandemic
    Ria Novianti, Meyke Garzia · 2020 · Journal Of Teaching And Learning In Elementary Education
  93. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication
    Yusuke Sakai, Kengo Kawachi, Yutaka Terada, Hiroko Omori, Yoshiharu Matsuura, Wataru Kamitani · 2017 · Virology
  94. Positive Epstein-Barr Virus Detection in Corona Virus Disease 2019 (COVID-19) Patients
    Ting Chen, Jiayi Song, Hongli Liu, Hongmei Zheng, Changzheng Chen · 2020 · Scientific Reports
  95. Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease
    Mingyue Li, Weina Guo, Yalan Dong, Xiaobei Wang, Die Dai, Xingxing Liu, Yiquan Wu, Mengmeng Li, Wenjing Zhang, Haifeng Zhou et al. · 2020 · Frontiers in Immunology
  96. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
    Caio Perez Gomes, Danilo Euclides Fernandes, Fernanda Maria Casimiro da Fonseca, Gustavo Ferreira da Mata, Michelle Tiveron Passos Riguetti, Patrícia Varela, Gianna Mastroianni Kirsztajn, João Bosco Pesquero · 2020 · Frontiers in Cellular and Infection Microbiology
  97. Testing for COVID-19: A way to lift confinement restrictions
    OECD · 2020 · OECD policy responses to coronavirus (Covid-19)
  98. Computational Determination of Potential Inhibitors of SARS-CoV‑2 Main Protease
    Sơn Tùng Ngô, Ngoc Quynh Anh Pham, Ly Le, Duc-Hung Pham, Van V. Vu · 2020 · Journal of Chemical Information and Modeling
  99. COVID-19: Progress in diagnostics, therapy and vaccination
    Xue Liu, Chao Liu, Gang Liu, Wenxin Luo, Ningshao Xia · 2020 · Theranostics
  100. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
    Pranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit · 2020 · PLoS Computational Biology